MedPath

Analysis of Extraperitoneal Rectal Neoplasms Between 3D Endorectal Ultrasonography and Magnification Chromoendoscopy

Not Applicable
Conditions
Rectal Cancer Stage I
Rectal Cancer
Interventions
Procedure: three-dimensional endorectal ultrasonography
Registration Number
NCT04527939
Lead Sponsor
University of Sao Paulo
Brief Summary

ERUS-3D and CMI demonstrated good diagnostic accuracy in parietal staging of rectal extraperitoneal neoplasms, however with greater efficiency of the endoscopic method. The association of studies can improve diagnostic efficacy and influence the most appropriate approach.

Detailed Description

Larger lesions present less chance of deep parietal invasion. The methods show moderate agreement with each other for lesion size and distance from the anal verge and good agreement for the rectal wall percentage of involvement. Circumferential or almost circumferential lesions have a greater chance of postoperative stenosis. Patients with more advanced lesions on AP who underwent radical resections had lower overall survival.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
70
Inclusion Criteria

patients with diagnosis of mid or distal rectum neoplasms stage 1 -

Exclusion Criteria

advanced rectal cancer (stage II, III or IV)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
three-dimensional endorectal ultrasonographythree-dimensional endorectal ultrasonographythree-dimensional endorectal ultrasonography
magnification chromoendoscopy.three-dimensional endorectal ultrasonographymagnification chromoendoscopy.
Primary Outcome Measures
NameTimeMethod
Degree of parietal invasion (T),immediately after the procedure

Patients with Stage T after procedure

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Medicine School, Sao Paulo University

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath